Lukosis Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Trioxasalen (5mg)
Overview Lukosis Tablet
Vitiligo and psoriasis are treated with the medication, DermaClear tablets. These tablets curb excessive skin cell generation and promote repigmentation of hypopigmented areas. DermaClear should be ingested post-prandially, following your physician's prescribed dosage and regimen. Food intake enhances absorption and mitigates nausea. Dosage is individualized, based on your response and condition, and should continue as directed. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all concurrent medications, as interactions are possible. Common, typically transient side effects include nausea, pruritus, and erythema. Report any concerns to your doctor immediately. Photosensitivity is a known effect; therefore, utilize sunscreen and protective garments outdoors, avoiding sun exposure for eight hours post-administration. This medication is not suitable for individuals younger than fourteen. To minimize photosensitivity, limit consumption of foods such as limes, figs, parsley, parsnips, mustard, carrots, and celery.
Uses of Lukosis Tablet
Pigmentation disorders: vitiligo and psoriasis
Major Benefits of Lukosis Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lukosis Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer the medication with food.
Common Side effects of Lukosis Tablet:
- Itching
- Erythema (skin redness)
- Nausea
How to use Lukosis Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Lukosis Tablet with food.
How Lukosis Tablet works:
Vitiligo-affected skin responds to the photosensitizing effects of Lukosis Tablets when combined with UVA light therapy. The medication stimulates melanocytes, promoting the return of natural skin color in affected areas. Furthermore, Lukosis Tablets mitigate the accelerated cell proliferation characteristic of psoriasis, leading to a reduction in skin scaling and thickening.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lukosis Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on Lukosis Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Lukosis Tablet with breastfeeding are lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Driving ability may be unaffected by Lukosis Tablet; however, refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Lukosis Tablet in patients with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Lukosis Tablets in patients with liver disease appears to pose minimal risk. Existing evidence indicates that dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Lukosis Tablet :
NA
Facts to Know About Lukosis Tablet
| Label | Value |
|---|---|
| Chemical Type | Psoralen Derivative |
| Developing Habits | No. |
| Treatment Category | DERMATOLOGY |
| Action Class | Psoralens and related compounds |
3,018 People bought this recently